Edmonton, Canada
Medo.ai, established in 2017, is at the forefront of revolutionizing the medical diagnostic industry by simplifying ultrasound technology. The company's slogan, "Ultrasound made simple," encapsulates its mission to make expert ultrasound diagnosis accessible to any clinician via point-of-care technology augmented with artificial intelligence and cloud computing.
Operating out of Canada, Medo.ai is firmly positioned within the AI, Biotechnology, Health Care, Medical Devices, and Machine Learning sectors. Their innovative solution allows for the early detection and monitoring of various medical conditions, from screening newborns for abnormalities in remote areas to diagnosing common diseases in family doctor offices.
The company last secured funding through a Convertible Note investment on 01 June 2021, backed by Qualgro VC. This investment highlights Medo.ai's ongoing commitment to transforming healthcare delivery by leveraging cutting-edge technologies.
